Models of care for neonatal abstinence syndrome: What works?

Opioid use disorders and the prescription of long-acting medications for their treatment have increased dramatically over the last decade among pregnant women. Newborns who experience prolonged in utero opioid exposure may develop neonatal abstinence syndrome (NAS). Until recently, much of the focus on improving care for NAS has been on pharmacologically-based care models. Recent studies have illustrated the benefits of rooming-in and parental presence on NAS outcomes. Single center Quality Improvement (QI) initiatives demonstrate the benefits of non-pharmacologic care bundles and symptom prioritization in decreasing the proportion of infants pharmacologically treated and length of hospital stay. Little remains known about the impact of these varied cared models on maternal-infant attachment and mental health. In this review article, we will propose an optimal model of care to improve short- and long-term outcomes for newborns, their mothers and families, and perinatal care systems.

• Publication year

  2019

• Venue

  Seminars in Fetal & Neonatal Medicine

• Publication date

  2019-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.SINY.2019.01.004PMID 30926259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Substance exposed infants need for attachment

  2019cited by this paper
• Outpatient pharmacologic weaning for neonatal abstinence syndrome: a systematic review

  2018cited by this paper
• Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial

  2018cited by this paper
• Ohio Perinatal Quality Collaborative Improves Care of Neonatal Narcotic Abstinence Syndrome

  2018cited by this paper
• Outpatient Pharmacotherapy for Neonatal Abstinence Syndrome

  2018cited by this paper
• Social Ecological Examination of Factors That Influence the Treatment of Newborns With Neonatal Abstinence Syndrome

  2018cited by this paper
• Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts.

  2018cited by this paper
• Retrospective study found that outpatient care for infants exposed to drugs during pregnancy was sustainable and safe

  2018cited by this paper
• A Novel Approach to Assessing Infants With Neonatal Abstinence Syndrome.

  2018cited by this paper
• Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment

  2018cited by this paper
• Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome

  2018cited by this paper
• Incidence and Costs of Neonatal Abstinence Syndrome Among Infants With Medicaid: 2004–2014

  2018cited by this paper
• Association of Rooming-in With Outcomes for Neonatal Abstinence Syndrome: A Systematic Review and Meta-analysis

  2018cited by this paper
• Impact of Postpartum Mental Illness Upon Infant Development

  2017cited by this paper
• Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome

  2017cited by this paper
• Decreasing Total Medication Exposure and Length of Stay While Completing Withdrawal for Neonatal Abstinence Syndrome during the Neonatal Hospital Stay

  2017cited by this paper
• An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome

  2017cited by this paper
• A Practical Approach to Neonatal Opiate Withdrawal Syndrome

  2017cited by this paper
• Wide Variation Found in Care of Opioid-Exposed Newborns.

  2017cited by this paper
• Heightened sympathetic arousal is demonstrated by skin conductance responsivity to auditory stimuli in a small cohort of neonates with opiate withdrawal.

  2017cited by this paper
• Impact of Parental Presence at Infants' Bedside on Neonatal Abstinence Syndrome.

  2017cited by this paper
• A management strategy that reduces NICU admissions and decreases charges from the front line of the neonatal abstinence syndrome epidemic

  2017cited by this paper
• Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome

  2017cited by this paper
• Judging the Neonatal Abstinence Syndrome Assessment Tools to Guide Future Tool Development: The use of Clinimetrics as Opposed to Psychometrics

  2017cited by this paper
• Maternal substance use and child protection: a rapid evidence assessment of factors associated with loss of child care.

  2017cited by this paper
• Neonatal Abstinence Syndrome Management: A Review of Recent Evidence.

  2017cited by this paper
• Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale.

  2016cited by this paper
• Does concurrent in utero exposure to buprenorphine and antidepressant medications influence the course of neonatal abstinence syndrome?

  2016cited by this paper
• Measurement of neonatal abstinence syndrome: Evaluation of short forms.

  2016cited by this paper
• A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal

  2016cited by this paper
• Improving Care for Neonatal Abstinence Syndrome

  2016cited by this paper
• NEONATAL ABSTINENCE SYNDROME AND THE ATTACHMENT RELATIONSHIP.

  2016cited by this paper
• Neonatal Abstinence Syndrome: Presentation and Treatment Considerations

  2016cited by this paper
• The Mothering Experiences of Women With Substance Use Disorders

  2016cited by this paper
• Skin conductance at baseline and postheel lance reflects sympathetic activation in neonatal opiate withdrawal

  2016cited by this paper
• A Qualitative Study of Family Experience With Hospitalization for Neonatal Abstinence Syndrome.

  2016cited by this paper
• A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.

  2016cited by this paper
• Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013.

  2016cited by this paper
• Rooming-In to Treat Neonatal Abstinence Syndrome: Improved Family-Centered Care at Lower Cost

  2016cited by this paper
• Maternal psychiatric disorders and risk of preterm birth.

  2016cited by this paper
• Trauma-Informed Care in the NICU: Implications for Early Childhood Development

  2016cited by this paper
• The Impact of Kangaroo Mother Care on Stress Reactivity and Attachment in Opioid Dependent Mother-Infants Dyads

  2016cited by this paper
• Improving Access to Maternity Care for Women with Opioid Use Disorders: Colocation of Midwifery Services at an Addiction Treatment Program.

  2015cited by this paper
• Opioid Prescription Claims Among Women of Reproductive Age — United States, 2008–2012

  2015cited by this paper
• Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

  2015cited by this paper
• Implementation of a Neonatal Abstinence Syndrome Weaning Protocol: A Multicenter Cohort Study

  2015cited by this paper
• Oral Morphine Weaning for Neonatal Abstinence Syndrome at Home Compared with In-Hospital: An Observational Cohort Study

  2015cited by this paper
• Increasing Incidence and Geographic Distribution of Neonatal Abstinence Syndrome: United States 2009-2012

  2015cited by this paper
• The Impact of Breastfeeding on Postpartum Pain After Vaginal and Cesarean Delivery

  2015cited by this paper
• Prescription Opioid Epidemic and Infant Outcomes

  2015cited by this paper
• Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.

  2015cited by this paper
• Rooming-in care for infants of opioid-dependent mothers: Implementation and evaluation at a tertiary care hospital.

  2015cited by this paper
• Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.

  2015cited by this paper
• Rooming-in for Infants at Risk of Neonatal Abstinence Syndrome

  2015cited by this paper
• A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report

  2015cited by this paper
• Experiences of mothers of infants with neonatal abstinence syndrome in the neonatal intensive care unit.

  2014cited by this paper
• Home‐based detoxification for neonatal abstinence syndrome reduces length of hospital admission without prolonging treatment

  2014cited by this paper
• Heart rate variability evaluation in the assessment and management of in-utero drug-exposed infants

  2014cited by this paper
• Methadone versus morphine for treatment of neonatal abstinence syndrome: A prospective randomized clinical trial

  2014cited by this paper
• A Multicenter Cohort Study of Treatments and Hospital Outcomes in Neonatal Abstinence Syndrome

  2014cited by this paper
• Supporting Women with Substance Use Issues: Trauma-Informed Care as a Foundation for Practice in the NICU

  2014cited by this paper
• Effects of maternal depressive symptomatology during pregnancy and the postpartum period on infant–mother attachment

  2014cited by this paper
• Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.

  2014cited by this paper
• Neonatal Abstinence Syndrome: Evaluating the Effectiveness of an Evidence-Based Multidisciplinary Care Approach

  2014cited by this paper
• The effect of severe stress on early brain development, attachment, and emotions: a psychoanatomical formulation.

  2014cited by this paper
• Variation in treatment of neonatal abstinence syndrome in US Children's Hospitals, 2004–2011

  2014cited by this paper
• Increase in Prescription Opioid Use During Pregnancy Among Medicaid-Enrolled Women

  2014cited by this paper
• Maternal-preterm skin-to-skin contact enhances child physiologic organization and cognitive control across the first 10 years of life.

  2014cited by this paper
• Breastfeeding promotion for management of neonatal abstinence syndrome.

  2013cited by this paper
• Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.

  2013cited by this paper
• Maintenance agonist treatments for opiate-dependent pregnant women.

  2013cited by this paper
• Neonatal Abstinence Syndrome Management From Prenatal Counseling to Postdischarge Follow-up Care: Results of a National Survey.

  2013cited by this paper
• Profile of infants born to drug‐using mothers: A state‐wide audit

  2013cited by this paper
• Poised to connect: How early relationships

  2013cited by this paper
• Validation of the Finnegan Neonatal Abstinence Syndrome Tool–Short Form

  2013cited by this paper
• Neonatal Opiate Withdrawal and Rooming-In: A Retrospective Analysis of a Single Center Experience

  2013cited by this paper
• Increasing pregnancy-related use of prescribed opioid analgesics.

  2013cited by this paper
• Maternal smoking and increased risk of sudden infant death syndrome: a meta-analysis.

  2013cited by this paper
• Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.

  2013cited by this paper
• Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes.

  2012cited by this paper
• Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

  2012cited by this paper
• Early Start: A Cost–Beneficial Perinatal Substance Abuse Program

  2012cited by this paper
• Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient setting

  2012cited by this paper
• Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.

  2012cited by this paper
• Baby Cuddlers Make a Difference

  2012cited by this paper
• Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.

  2012cited by this paper
• Infant pupillary response to methadone administration during treatment for neonatal abstinence syndrome: a feasibility study.

  2012cited by this paper
• Neonatal Drug Withdrawal

  2012cited by this paper
• Cigarette Smoking and Neonatal Outcomes in Depressed and Nondepressed Opioid-dependent Agonist-Maintained Pregnant Patients

  2011cited by this paper
• The Relationship Between Maternal Opioid Agonists and Psychiatric Medications on Length of Hospitalization for Neonatal Abstinence Syndrome

  2011cited by this paper
• Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.

  2011cited by this paper
• Infant bonding and attachment to the caregiver: insights from basic and clinical science.

  2011cited by this paper
• Clinical Skills in Infant Mental Health: The First Three Years

  2011cited by this paper
• Mothers’ Breastfeeding Experiences in the NICU

  2011cited by this paper
• Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates

  2011cited by this paper
• Neonatal abstinence syndrome after methadone or buprenorphine exposure.

  2010cited by this paper
• Getting connected: How nurses can support mother/infant attachment in the neonatal intensive care unit

  2010cited by this paper
• Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants.

  2010cited by this paper
• Opiate treatment for opiate withdrawal in newborn infants.

  2010cited by this paper
• Neonatal abstinence syndrome—postnatal ward versus neonatal unit management

  2009cited by this paper

• Maternal Area of Residence and Outcomes for Mother–Infant Dyads with Perinatal Opioid Exposure

  2025cites this paper
• “We Were Just so Sad and Devastated”: NICU Nurses' Stories of Caring for Families With Substance‐Exposed Pregnancies

  2024cites this paper
• Non-pharmacologic and pharmacologic care of the neonate with opioid withdrawal syndrome.

  2024cites this paper
• Understanding Addiction in the Context of Perinatal Substance Use: A Reflection for Clinicians

  2023cites this paper
• “Will My Baby Be OK?” A Qualitative Analysis of Pregnant Women’s Suboxone® Online Forum Posts

  2023cites this paper
• The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention

  2023cites this paper
• Neonatal Abstinence Syndrome and non-pharmacological nursing care. A scoping review

  2023cites this paper
• Intrauterine Drug Exposure—What the Pediatrician Needs to Know

  2023cites this paper
• Current Trends in Care for Infants Diagnosed with Neonatal Abstinence Syndrome in Canada: A Discussion Paper

  2023cites this paper
• METHADONE AND MORPHINE FOR THE TREATMENT OF NEONATAL ABSTINENCE SYNDROME: A COMPARISON OF SAFETY AND EFFICACY

  2023cites this paper
• Exploring Perinatal Nursing Care for Opioid Use Disorder

  2022cites this paper
• Developments in Nursing Practice to Address Substance Use in the Perinatal Period.

  2022cites this paper
• The High Cost of Opioid Use in Pregnancy

  2022cites this paper
• Length of Stay Among Infants with Neonatal Abstinence Syndrome and Risk of Hospital Readmission

  2022cites this paper
• Physiologic dysregulation in newborns with prenatal opioid exposure: Cardiac, respiratory and movement activity.

  2022cites this paper
• Neonatal Abstinence Syndrome: Management and Role of APRN

  2021cites this paper
• Predictors of pharmacologic therapy for neonatal opioid withdrawal syndrome: a retrospective analysis of a statewide database

  2021cites this paper
• The Complexities Associated with Caring for Hospitalised Infants with Neonatal Abstinence Syndrome: The Perspectives of Nurses and Midwives

  2021cites this paper
• The Challenges to Promoting Attachment for Hospitalised Infants with NAS

  2021cites this paper
• Escaping the Finnegan - Is it time?

  2021cites this paper
• Developing a model of care for substance use in pregnancy and parenting services, Sydney, Australia: Service provider perspectives.

  2021cites this paper
• The Term Newborn: Prenatal Substance Exposure.

  2021cites this paper
• Increasing usage of mother’s own milk in neonates at risk of neonatal abstinence syndrome: MOM-NAS quality improvement initiative

  2021cites this paper
• Variations and similarities in neonatal abstinence syndrome care and management across tertiary care hospitals in West Virginia

  2021cites this paper
• Reduction of need for treatment and length of hospital stay following institution of a neonatal abstinence syndrome rooming-in program in Ontario, Canada.

  2021cites this paper
• Rooming-in for Infants at Risk for Neonatal Abstinence Syndrome: Outcomes 5 Years following Its Introduction as the Standard of Care at One Hospital

  2020cites this paper
• Neonatal Abstinence Syndrome.

  2020cites this paper
• The ACT NOW Clinical Practice Survey: Gaps in the Care of Infants With Neonatal Opioid Withdrawal Syndrome.

  2019cites this paper
• Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.

  2019cites this paper
• Time for the Finnegan Neonatal Abstinence Syndrome Scoring Tool to Be Retired?

  2019influential citation
• Non-pharmacological care for opioid withdrawal in newborns.

  2018influential citation